Patents matching “ophthalmic”

US 2019151500

OPHTHALMIC VISCOELASTIC COMPOSITIONS

BAUSCH & LOMB [US] · Granted May 23, 2019 · Expires May 18, 2039

US 10265375

Ophthalmic compositions

AURINIA PHARMACEUTICALS INC. · Granted Apr 23, 2019 · Expires Apr 18, 2039

US 10016388

Ophthalmic lens, intraocular lens, and ophthalmic lens package having ophthalmic lens

HON HAI PRECISION INDUSTRY CO., LTD. · Granted Jul 10, 2018 · Expires Jul 5, 2038

US 9844530

Ophthalmic solutions for glaucoma and conjunctivitis treatment

AXIM BIOTECHNOLOGIES. INC. · Granted Dec 19, 2017 · Expires Dec 14, 2037

US 9814695

Ophthalmic solutions for glaucoma and conjunctivitis treatment

AXIM BIOTECHNOLOGIES. INC. · Granted Nov 14, 2017 · Expires Nov 9, 2037

US 9804298

Ophthalmic lens material

HON HAI PRECISION INDUSTRY CO., LTD. · Granted Oct 31, 2017 · Expires Oct 26, 2037

US 9801813

Preservative-free ophthalmic pharmaceutical formulation

SENTISS PHARMA PRIVATE LIMITED · Granted Oct 31, 2017 · Expires Oct 26, 2037

US 9709703

Ophthalmic lens material, ophthalmic lens, and method for making the same

HON HAI PRECISION INDUSTRY CO., LTD. · Granted Jul 18, 2017 · Expires Jul 13, 2037

US 2016213609

OPHTHALMIC SUSPENSION COMPOSITION

BAUSCH & LOMB [US] · Granted Jul 28, 2016 · Expires Jul 23, 2036

US 9017725

Topical drug delivery systems for ophthalmic use

AURINIA PHARMACEUTICALS INC. · Granted Apr 28, 2015 · Expires Apr 23, 2035

US 8945604

Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication

The Regents of the University of California · Granted Feb 3, 2015 · Expires Jan 29, 2035

US 2014206764

Poly(Nitrogen/Amine) Derivatives of a Natural Wax and Ophthalmic Compositions

BAUSCH & LOMB [US] · Granted Jul 24, 2014 · Expires Jul 19, 2034

US 8785393

Ophthalmic pharmaceutical compositions of DP2 receptor antagonists

Panmira Pharmaceuticals, LLC · Granted Jul 22, 2014 · Expires Jul 17, 2034

US 8679557

Synergistic herbal ophthalmic formulation for lowering the intra ocular pressure in case of glaucoma

SENTISS PHARMA PRIVATE LIMITED · Granted Mar 25, 2014 · Expires Mar 20, 2034

US 8563028

Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication

The Regents of the University of California · Granted Oct 22, 2013 · Expires Oct 17, 2033

US 8529907

Methods of treating ophthalmic disorders

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 10, 2013 · Expires Sep 5, 2033

US 2013210912

Ophthalmic Pharmaceutical Compositions and Methods of Making and Using Same

BAUSCH & LOMB [US] · Granted Aug 15, 2013 · Expires Aug 10, 2033

US 8324171

Ophthalmic compositions containing diglycine

BURKE SUSAN E [US] · Granted Dec 4, 2012 · Expires Nov 29, 2032

US 8153156

Hydrogel nanocompsites for ophthalmic applications

The United States of America as represented by the Department of Veteran Affairs · Granted Apr 10, 2012 · Expires Apr 5, 2032

US 7531173

Ophthalmic composition of a VEGF antagonist

REGENERON PHARMACEUTICALS, INC. · Granted May 12, 2009 · Expires May 7, 2029

DE 102005046769

Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus)

BERLIN CHEMIE AG [DE] · Granted Apr 5, 2007 · Expires Mar 31, 2027

US 6531120

Ophthalmic histamine compositions and uses thereof

Maxim Pharmaceuticals, Inc. · Granted Mar 11, 2003 · Expires Mar 6, 2023